363151-21-7

SSR182289 Chemical Structure
363151-21-7

Chemical Structure

SSR182289

Synonym(s): SSR182289A free base

  • CAS No.: 363151-21-7
  • Formula:C30H33F2N5O4S
  • Molecular Weight:597.68

IUPAC Name: (S)-N-(3-(N-(5-(5-aminopyridin-2-yl)-1-(4-(difluoromethylene)piperidin-1-yl)-1-oxopentan-2-yl)sulfamoyl)-[1,1'-biphenyl]-2-yl)acetamide

InChIKey: CZDGBCPZABMRBF-SANMLTNESA-N

SMILES: CC(NC1=C(S(=O)(N[C@H](C(N2CC/C(CC2)=C(F)/F)=O)CCCC3=NC=C(N)C=C3)=O)C=CC=C1C4=CC=CC=C4)=O

Biological Activity: SSR182289 (SSR182289A free base) is a selective and potent orally active thrombin inhibitor. SSR182289 competitively and selectivity inhibits human thrombin (Ki=0.031 μM). SSR182289 demonstrates anticoagulant activity in vitro (thrombin time EC100=96 nM) and inhibits tissue factor-induced thrombin generation (IC50=0.15 μM) in human plasma. SSR182289 inhibits thrombin-induced aggregation of human platelets (IC50=32 nM), but has no effect on aggregation induced by other platelet agonists [1][2].

Cat. No. Product Name Purity Description Pricing
HY-19674
SSR182289 SSR182289 (SSR182289A free base) is a selective and potent orally active thrombin inhibitor. SSR182289 competitively and selectivity inhibits human thrombin (Ki=0.031 μM). SSR182289 demonstrates anticoagulant activity in vitro (thrombin time EC100=96 nM) and inhibits tissue factor-induced thrombin generation (IC50=0.15 μM) in human plasma. SSR182289 inhibits thrombin-induced aggregation of human platelets (IC50=32 nM), but has no effect on aggregation induced by other platelet agonists .
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References